| 1 |
24843581 | Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus. | 2012 Jun 6 |
1 |
| 2 |
18505128 | [Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes]. | 2008 Apr |
1 |
| 3 |
17712875 | Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes. | 2007 Aug |
1 |
| 4 |
15324515 | Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes. | 2004 Aug |
1 |
| 5 |
11194214 | Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes. | 2001 Jan |
1 |
| 6 |
11472451 | Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study. | 2001 May |
1 |
| 7 |
10631622 | Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study. | 2000 Jan |
1 |
| 8 |
9868989 | Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs. | 1998 |
1 |